Notably, orientin reduced fibrosis, inflammatory responses, and cardiomyocyte apoptosis
But many people on GLP-1 medications experience a significant change in their bowel habits without meeting that clinical threshold
Tirzepatide is actively studied in research on dual incretin receptor pharmacology, adipose tissue biology, beta-cell preservation, NASH resolution, obstructive sleep apnea, heart failure with preserved ejection fraction (HFpEF), and polycystic kidney disease
July 10, 2021 Also see our answer to the question: Do supplements help with Parkinson's disease treatment or prevention
Evidence suggests that GLP-1RAs do not directly prevent gout attacks, but are effective in managing cardiometabolic conditions commonly associated with gout and other arthritides
doi:10.1006/abbi.1997.0566